InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.00%
)
US TECH 100
19,515.20
(
0.09%
)
Dow Jones
42,052.19
(
0.00%
)
Brent Oil
74.99
(
1.23%
)
Bitcoin
68,542.91
(
-0.30%
)
Post# of 43853
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

lux1

Send PM Follow Ignore
Followers 1
Posts 206
Boards Moderated 0
Alias Born 04/06/2013

lux1

Re: None

Sunday, 11/19/2017 4:16:24 PM

Sunday, November 19, 2017 4:16:24 PM

Post# of 43853
I'm surprised how IRX Therapeutics ( a private company) has tested in a P2 a drug ,IRX-2, that is the copy of Multikine. Also the trial is exactly the same of the Cel-Sci trial: interleukines mixture 21 days before surgery or x-ray.
They showed a good OS in HNSCC,furthermore they are testing their drug also in some other diseases exactly like CVM.
I think they are trying to duplicate CVM because of our troubles, surely they believe in this kind of drug.
Does anyone know about it?
TIA
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CVM News
More CVM News
InvestorsHub NewsWire

Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM

Start posting your company's news
Only $200 per official company press release!